200,000+ products from a single source!
sales@angenechem.com
CAS No: 127759-89-1 Catalog No: AG000XDI MDL No:MFCD00870586
Title | Journal |
---|---|
Inactivity of the bicyclic pyrimidine nucleoside analogues against simian varicella virus (SVV) does not correlate with their substrate activity for SVV-encoded thymidine kinase. | Biochemical and biophysical research communications 20040319 |
In vitro activity of potential anti-poxvirus agents. | Antiviral research 20030101 |
A novel nonnucleoside inhibitor specifically targets cytomegalovirus DNA maturation via the UL89 and UL56 gene products. | Journal of virology 20011001 |
Acyclic/carbocyclic guanosine analogues as anti-herpesvirus agents. | Nucleosides, nucleotides & nucleic acids 20010101 |
Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8. | Reviews in medical virology 20010101 |
Antiviral efficacy of lobucavir (BMS-180194), a cyclobutyl-guanosine nucleoside analogue, in the woodchuck (Marmota monax) model of chronic hepatitis B virus (HBV) infection. | Antiviral research 20001201 |
Ribavirin and mycophenolic acid potentiate the activity of guanine- and diaminopurine-based nucleoside analogues against hepatitis B virus. | Antiviral research 20001101 |
In vivo anti-papillomavirus activity of nucleoside analogues including cidofovir on CRPV-induced rabbit papillomas. | Antiviral research 20001101 |
Lamivudine, adefovir and tenofovir exhibit long-lasting anti-hepatitis B virus activity in cell culture. | Journal of viral hepatitis 20000101 |
Guanosine analogues as anti-herpesvirus agents. | Nucleosides, nucleotides & nucleic acids 20000101 |
Hydroxyurea potentiates the antiherpesvirus activities of purine and pyrimidine nucleoside and nucleoside phosphonate analogs. | Antimicrobial agents and chemotherapy 19991201 |
Human cytomegalovirus: challenges, opportunities and new drug development. | Antiviral chemistry & chemotherapy 19990901 |
Selective activity of various antiviral compounds against HHV-7 infection. | Antiviral research 19990801 |
Susceptibility of lamivudine-resistant hepatitis B virus to other reverse transcriptase inhibitors. | The Journal of clinical investigation 19990615 |
Identification of BMS-200475 as a potent and selective inhibitor of hepatitis B virus. | Antimicrobial agents and chemotherapy 19970701 |
Susceptibility of human cytomegalovirus to two-drug combinations in vitro. | Antiviral therapy 19961201 |
Analysis of phosphorylation pathways of antiherpesvirus nucleosides by varicella-zoster virus-specific enzymes. | Antimicrobial agents and chemotherapy 19960401 |
Efficacy of BMS-180194 against experimental cytomegalovirus infections in immunocompromised mice. | Antiviral research 19960301 |
Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6. | Antiviral research 19951201 |
Synthesis and antiviral activity of carbocyclic oxetanocin analogues (C-OXT-A, C-OXT-G) and related compounds. II. | Chemical & pharmaceutical bulletin 19930301 |
Effects of purine nucleoside analogues with a cyclobutane ring and erythromycin A oxime derivatives on duck hepatitis B virus replication in vivo and in cell culture and HIV-1 in cell culture. | Journal of medical virology 19911101 |
Antiviral activity of oxetanocins against varicella-zoster virus. | Antimicrobial agents and chemotherapy 19910701 |
Synthesis and antiviral activity of enantiomeric forms of cyclobutyl nucleoside analogues. | Journal of medicinal chemistry 19910401 |
Cyclobut-A and cyclobut-G: broad-spectrum antiviral agents with potential utility for the therapy of AIDS. | Journal of medicinal chemistry 19900501 |
Cyclobut-A and cyclobut-G, carbocyclic oxetanocin analogs that inhibit the replication of human immunodeficiency virus in T cells and monocytes and macrophages in vitro. | Antimicrobial agents and chemotherapy 19900201 |
(+-)-(1 alpha,2 beta,3 alpha)-9-[2,3-bis(hydroxymethyl)-cyclobutyl] guanine [(+-)-BHCG or SQ 33,054]: a potent and selective inhibitor of herpesviruses. | Antiviral research 19900101 |
© 2019 Angene International Limited. All rights Reserved.